They found that ANXA1/2/3/5/6/7/8 were highly expressed in basal-subtype MIBC, while ANXA4/9/10/11 were mainly expressed in luminal-subtype MIBC, which might be used as potential markers for subtype classification of BC. Here, ANXA1 is linked to breast cancer.